Identification of a Protein Biomarker Signature Using Reverse Phase Protein Arrays (RPPA) for Risk Classification of Estrogen Receptor-Positive Breast CancerTuesday, 5 March 2013 at 11:15 Add to Calendar ▼2013-03-05 11:15:002013-03-05 12:15:00Europe/LondonIdentification of a Protein Biomarker Signature Using Reverse Phase Protein Arrays (RPPA) for Risk Classification of Estrogen Receptor-Positive Breast Cancer Advances in Microarray Technology in Barcelona, SpainBarcelona, SpainSELECTBIOenquiries@selectbiosciences.com Using reverse phase protein arrays (RPPA) a protein signature was identified that can distinguish between high and low risk luminal breast cancer. |